Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × FCN-437c × Clear all

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor, Adult 1

Interventions

pembrolizumab 877 Carboplatin 823 Paclitaxel 807 Gemcitabine 675 Cisplatin 651 Docetaxel 612 Bevacizumab 545 Nivolumab 431 Pemetrexed 423 Cyclophosphamide 411 Capecitabine 403 Fluorouracil 347 Dexamethasone 341 Rituximab 339 Oxaliplatin 294 Injections 288 atezolizumab 271 Trastuzumab 266 Cetuximab 245 Leucovorin 240 Prednisone 227 Irinotecan 225 130-nm albumin-bound paclitaxel 221 Doxorubicin 214 Ipilimumab 201 Lenalidomide 197 Fulvestrant 192 fludarabine 183 durvalumab 180 Drug Therapy 175

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03951116 2022-03-16

FCN-437c

Fochon Pharmaceuticals, Ltd.

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡